Boris Weiss, CEO of Medicare Pharmaceuticals, provides a brief overview of the difficulties to start clinical trials in Canada and his proposed pilot program to alleviate some of those difficulties.
Read More
Boris Weiss, CEO of Medipure Pharmaceuticals recently talked to us about the numerous clinical trials his company has in development throughout the world, including studies in Canada, United States, India, and Croatia.
Read More
90 plus years ago, the book Statistical Methods for Research Workers established the P< .05 concept as a gold standard. But is it really a good benchmark?
Read More
Canadian pharmaceutical company, Prometic Life Sciences, announced the latest data from their lead candidate, PBI-4050, to treat idiopathic pulmonary fibrosis (IPF), presented at the American Thoracic Society (ATS) 2018 International Conference being held in San Diego, California.
Read More
The goal is to develop a clinical trial that will limit the number of questions that doctors, insurance companies, patients, caregivers, and regulatory agencies will have about the trial’s results.
Read More
Canadian pharmaceutical company, Prometic Life Sciences Inc provided an update on their ongoing Phase 2 clinical trial involving the use of PBI-4500 to treat patients with Alström syndrome. Alström syndrome is a rare genetic condition due to mutations in the ALMS1 gene.
Read More
Shire’s Hunter Syndrome Trial Fails to Meet Primary Endpoint While Advocacy Group Starts its Own Gene Therapy Trial.
Read More
Clinical trials are designed in escalating complexity to determine safety and efficacy of drugs before they are can be prescribed to treat patients.
Read More
